1. Halliday WJ. Historical background and aspects of the mechanism of leukocyte adherence inhibition. Cancer Res 39:558. 1979.
3. Sherlock S. Diseases of the liver and biliary system. 6th Ed. Oxford: Blackwell-Mosby, 275. 1981.
4. de Groote J, Desmet V, Gedigk P, et al. A classification of chronic hepatitis. Lancet 2:626. 1968.
5. Gevety RJ, Schweitzer IL. Viral hepatitis type B during pregnancy, the neonatal period and infancy. J Pediatr 90:368. 1977.
6. Hoofnagle JH, Dusheilo GM, Schafer DF, Jones EA, Micetich KC, Young RC, Costa J. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Int Med 96:477. 1982.
7. Vladimir H. The use of the assay to measure immunity in animal models. 5:123. 1982.
8. Koppi TA, Halliday WJ, Mckenzie IF. Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumors. I Cell and serum activity detected by leukocyte adherence inhibition. JNCI 66:1089. 1981.
9. Grosset N, Thomson DMP. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Cancer Res 35:2571. 1975.
10. Halliday WJ, Maluish A, Little JH, Davis NC. Leukocyte adherence inhibition and specific immunoreactivity in malignat melanoma. Int J Cancer 16:646. 1975.
11. Halliday WM, Miller S. Leukocyte adherence inhibition. A simple test for cell-mediated tumor immunity and serum blocking factors. Int J Cancer 9:477. 1972.
12. Goldrosen MH, Russo AJ, Howell JH, Leveson SH, Moore MC, Holyoke EK, Ho Douglas. Evaluation of micro-leukocyte adherence inhibition as a immunodiagnostic test for pancreatic cancer. J Cancer 36:542. 1976.
13. Maluish AE, Halliday WJ. Hemocytometer leukocyte adherence inhibition technique. Cancer Res 39:625. 1979.
14. Sanner T, Brennhold I, Christensen I, Jorgensen O, Kvaloy S. Cellular anti-tumor immune response in woman with risk factors for breast cancer. Cancer Res 39:645. 1979.
15. Shani A, Ritts RE, Thynne GS, Weiland LH, Silvers A, Moertel CG, GO VLW. A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels. Int J cancer 22:113. 1978.
16. Thomson DMP. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood. Cancer Res 39:627. 1979.
18. Kaneti J, Thomson DMP, Reid EC. Prostaglandin E
2, affects the tumor immune response in prostatic cancer. J Urol 126:65. 1981.
19. Grosser N, Thomson DMP. The leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumor immunity. Int J Cancer 18:58. 1976.
20. Thomson DMP, Phelan K, Scanzano R, Fink A. The angulation of the human antitumor immune response to organ-specific neoantigens. Transplant Process 13:1952. 1981.
21. Thomson DMP, Phelan k, Schwartz Scanzano R. A dye-extraction method to quantitate the standard and PGE2 stimulation tube LAI assay. Tumor Diagnostic 2:68. 1981.
22. Macfarlane JK, Thomson DMP, Shenouda G, Scanzano R. Predictive value of tube leukocyte adherence inhibition assay for breast, colorectal, stomach and pancreatic cancer. Cancer 49:118. 1982.
23. Ayeni AO, Thomsom DMP, Macfarlane JK, Daly D. A comparison of tube LAI assay and standard physical methods for diagnosing colorectal cancer. Cancer 48:1855. 1981.
24. Goldrosen MH, Dasmahapatra K, Jenkins D, Howell JG, Arbuck SG, Moore MC, Douglass HO. Microplate leukocyte adherence inhibition (LAI) assay in pancreatic cancer. Cancer 47:1641. 1981.
25. Ablin RJ, Bhatti RA. Cell-mediated immunity in prostatic tissue. Cancer 29:1570. 1972.
26. Ablin RJ, Bhatti RA. Cell-mediated immunity in prostatic cancer. Clin Oncol 6:253. 1980.
27. Ablin RJ, Bhatti RA, Guinan PD. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancel. Eur J Cancer 13:699. 1977.
28. Rose NR, Choe BK, Pontes EJ. Double antibody immunoenzyme assay for human prostatic acid phosphatase. Clin Chem 26:1854. 1980.
29. Wajsman Z, Chu TM, Murphy GP, Saroff J, Slack N. Two new direct and specific methods of acid phosphatase determination. National field trial Urology 13:3. 1979.
30. Bennett JC. Textbook of Rheumatology. In: Kelley WN, Harris ED, Ruddy S, Slelge B, eds. Chap. 58. The Etiology of Rheumatoid Arthritis. Saunders, Philadephia, Pennsylvania: 1981.
31. Tannenbaum H. The leukocyte adherence inhibition assay in human and experimental rheumatic disease. J Rheum 2:207. 1982.
32. Tannenbaum H, Poskitt K. The leukocyte adherence inhibition assay in adjuvant-induced disease in rats. J Rheum 7:293. 1980.
33. Seo JG, Koh GU. Specific Antigen Mediated Leukocyte Adherence Inhibition (LAI) Part II Trial of LAI test in hepatitis B surface antigen and antibody system and assessment of the mechanism. Korean J Gastroenterol 16:197. 1984.